Testing butylphthalide for blocked brain arteries
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if butylphthalide, a drug that may improve blood flow, helps people with a narrowed artery in the brain (the middle cerebral artery) after a recent stroke or mini-stroke. It is for people aged 55-75 with at least one risk factor like high blood pressure or diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 75 years old
- You have had a stroke or transient ischemic attack (TIA) within the last 7 days
- You have severe narrowing (70-99%) of the main part of the middle cerebral artery, confirmed by an MRI
- Your stroke symptoms are mild to moderate (NIHSS score 20 or less, meaning you can move and speak without major help)
- You are able to have an MRI scan
- You have at least one of these risk factors: high blood pressure, diabetes, high cholesterol, or smoking
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication (bevifibatide) to see which dose works best for people having an ischemic stroke who cannot get standard treatments like clot-busting drugs or a procedure to remove the clot. It aims to improve recovery by stopping clots from getting worse.
This trial tests the drug tirofiban (a blood thinner) to prevent another stroke in people who have had a mild stroke or high-risk TIA and have a narrowed artery in the brain. It must be started within 24 hours of symptoms.
This pilot study tests a catheter treatment called a drug-coated balloon to treat repeat narrowing inside a previously placed brain stent. It may help people whose stent has narrowed again and is causing reduced blood flow or stroke/TIA symptoms despite best medical therapy.
This trial tests whether a medication called butylphthalide can help reduce brain swelling that sometimes occurs after emergency endovascular treatment (a minimally invasive procedure to restore blood flow) for certain types of stroke.
This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.
This trial tests whether a cholesterol-lowering medication (PCSK9 inhibitor) can help prevent further strokes in people who have recently had a stroke or mini-stroke due to a narrowed artery in the brain. It is for adults 30 to 80 years old who meet specific health criteria.
Hear when a new Intracranial Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.